Evidence for a role of Hsp70 in the neuroprotection induced by heat shock pre-treatment against 3,4-methylenedioxymethamphetamine toxicity in rat brain

Journal of Neurochemistry

Volumn 101, Issue 5, 2007, Pages 1272-1283

  Escobedo, Isabel ^a   Peraile, Ines ^a   Orio, Laura ^a   Colado, M Isabel ^a   O'Shea, Esther ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

3,4 methylenedioxymethamphetamine (MDMA, 'ecstasy'); Heat shock protein 70 (Hsp70); Hyperthermia; Neuroprotection; Neurotoxicity; Preconditioning

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; FLUOXETINE; GELDANAMYCIN; HEAT SHOCK PROTEIN 70; HYDROXYL RADICAL; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; BRAIN TOXICITY; CONTROLLED STUDY; ENVIRONMENTAL TEMPERATURE; FRONTAL CORTEX; HEAT SHOCK; HYPERTHERMIA; HYPOTHERMIA; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECTUM TEMPERATURE; ROOM TEMPERATURE; SHORT SURVEY;

ANIMALS; BODY TEMPERATURE; BRAIN; BRAIN CHEMISTRY; EPISTASIS, GENETIC; FLUOXETINE; GENE EXPRESSION REGULATION; HALLUCINOGENS; HEATING; HSP70 HEAT-SHOCK PROTEINS; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROTOXICITY SYNDROMES; RATS; REACTIVE OXYGEN SPECIES; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

RATTUS;

EID: 34248159564     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04459.x     Document Type: Short Survey

References (58)

1. Abe H. Nowak T. S. Jr. (2000) Postischemic temperature as a modulator of the stress response in brain: dissociation of heat shock protein 72 induction from ischemic tolerance after bilateral carotid artery occlusion in the gerbil. Neurosci Lett. 295, 54 58.
2. Adori C., Ando R. D., Kovacs G. G. Bagdy G. (2006) Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns. J. Comp. Neurol. 497, 251 269.
3. Barone F. C., White R. F., Spera P. A., Ellison J., Currie R. W., Wang X. Feuerstein G. Z. (1998) Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29, 1937 1951.
4. Battaglia G., Yeh S. Y., O'Hearn E., Molliver M. E., Kuhar M. J. De Souza E. B. (1987) 3,4-Methylenedioxymethamphetamine and 3,4- methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J. Pharmacol. Exp. Ther. 242, 911 916.
5. Baumann M. H., Wang X. Rothman R. B. (2007) 3,4- Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) March 16; [Epub ahead of print].
6. Brambrink A. M., Noga H., Astheimer A., Heimann A. Kempski O. (2004) Pharmacological preconditioning in global cerebral ischemia. Acta Neurochir. Suppl. 89, 63 66.
7. Broening H. W., Bowyer J. F. Slikker W. Jr. (1995) Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (+/-)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J. Pharmacol. Exp. Ther. 275, 325 333.
8. Callaway C. W., Wing L. L. Geyer M. A. (1990) Serotonin release contributes to the locomotor stimulant effects of 3,4- methylenedioxymethamphetamine in rats. J. Pharmacol. Exp. Ther. 254, 456 464.
9. Chiueh C. C., Huang S. J. Murphy D. L. (1992) Enhanced hydroxyl radical generation by 2'-methyl analog of MPTP: suppression by clorgyline and deprenyl. Synapse 11, 346 348.
10. Colado M. I., O'Shea E., Granados R., Murray T. K. Green A. R. (1997) In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('Ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine. Br. J. Pharmacol. 121, 889 900.
11. Dirnagl U., Simon R. P. Hallenbeck J. M. (2003) Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26, 248 254.
12. Esteban B., O'Shea E., Camarero J., Sanchez V., Green A. R. Colado M. I. (2001) 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose. Psychopharmacology (Berl.) 154, 251 260.
13. Giovanni A., Liang L. P., Hastings T. G. Zigmond M. J. (1995) Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64, 1819 1825.
14. Gold L. H., Hubner C. B. Koob G. F. (1989) A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. Psychopharmacology (Berl.) 99, 40 47.
15. Gordon C. J., Watkinson W. P., O'Callaghan J. P. Miller D. B. (1991) Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat. Pharmacol. Biochem. Behav. 38, 339 344.
16. Green A. R., Mechan A. O., Elliott J. M., O'Shea E. Colado M. I. (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy"). Pharmacol. Rev. 55, 463 508.
17. Green A. R., O'Shea E. Colado M. I. (2004) A review of the mechanisms involved in the acute MDMA (Ecstasy)-induced hyperthermic response. Eur. J. Pharmacol. 500, 3 13.
18. Halliwell B., Kaur H. Ingelman-Sundberg M. (1991) Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note. Free Radic. Biol. Med. 10, 439 441.
19. Hewitt K. E. Green A. R. (1994) Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats. Neuropharmacology 33, 1589 1595.
20. Jiang J. Y., Lyeth B. G., Clifton G. L., Jenkins L. W., Hamm R. J. Hayes R. L. (1991) Relationship between body and brain temperature in traumatically brain-injured rodents. J. Neurosurg. 74, 492 496.
21. Kiang J. G. Tsokos G. C. (1998) Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol. Ther. 80, 183 201.
22. Kitagawa K., Matsumoto M., Kuwabara K., Tagaya M., Ohtsuki T., Hata R., Ueda H., Handa N., Kimura K. Kamada T. (1991) 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res. 561, 203 211.
23. König J. F. R. Klippel R. A. (1963) The Rat Brain. A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Robert E Krieger Publishing Co. Inc., New York.
24. Kramer H. K., Poblete J. C. Azmitia E. C. (1997) Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter. Neuropsychopharmacology 17, 117 129.
25. Lindquist S. (1986) The heat-shock response. Annu. Rev. Biochem. 55, 1151 1191.
26. Lowry O. H., Rosebrough N. J., Farr A. L. Randall R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265 275.
27. Lu A., Ran R., Parmentier-Batteur S., Nee A. Sharp F. R. (2002) Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia. J. Neurochem. 81, 355 364.
28. Malberg J. E. Seiden L. S. (1998) Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J. Neurosci. 18, 5086 5094.
29. Matsumori Y., Hong S. M., Aoyama K., Fan Y., Kayama T., Sheldon R. A., Vexler Z. S., Ferriero D. M., Weinstein P. R. Liu J. (2005) Hsp70 overexpression sequesters AIF and reduces neonatal hypoxic/ischemic brain injury. J. Cereb. Blood Flow Metab. 25, 899 910.
30. Mechan A. O., Esteban B., O'Shea E., Elliott J. M., Colado M. I. Green A. R. (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') to rats. Br. J. Pharmacol. 135, 170 180.
31. Molliver M. E., Berger U. V., Mamounas L. A., Molliver D. C., O'Hearn E. Wilson M. A. (1990) Neurotoxicity of MDMA and related compounds: anatomic studies. Ann. NY Acad. Sci. 600, 649 661.
32. O'Hearn E., Battaglia G., De Souza E. B., Kuhar M. J. Molliver M. E. (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 8, 2788 2803.
33. O'Shea E., Granados R., Esteban B., Colado M. I. Green A. R. (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('Ecstasy'). Neuropharmacology 37, 919 926.
34. O'Shea E., Escobedo I., Orio L., Sanchez V., Navarro M., Green A. R. Colado M. I. (2005) Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology 30, 1312 1323.
35. O'Shea E., Orio L., Escobedo I., Sanchez V., Camarero J., Green A. R. Colado M. I. (2006) MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature. Br. J. Pharmacol. 148, 778 785.
36. Omata N., Murata T., Takamatsu S., Maruoka N., Yonekura Y., Fujibayashi Y. Wada Y. (2006) Region-specific induction of hypoxic tolerance by expression of stress proteins and antioxidant enzymes. Neurol. Sci. 27, 74 77.
37. Orio L., O'Shea E., Sanchez V., Pradillo J. M., Escobedo I., Camarero J., Moro M. A., Green A. R. Colado M. I. (2004) 3,4-Methylenedioxymethamphetamine increases interleukin-1beta levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5-HT depletion. J. Neurochem. 89, 1445 1453.
38. Plumier J. C., Krueger A. M., Currie R. W., Kontoyiannis D., Kollias G. Pagoulatos G. N. (1997) Transgenic mice expressing the human inducible Hsp70 have hippocampal neurons resistant to ischemic injury. Cell Stress Chaperones 2, 162 167.
39. Riabowol K. T., Mizzen L. A. Welch W. J. (1988) Heat shock is lethal to fibroblasts microinjected with antibodies against Hsp70. Science 242, 433 436.
40. Sanchez V., Camarero J., Esteban B., Peter M. J., Green A. R. Colado M. I. (2001) The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('Ecstasy')-induced degeneration of 5-HT nerve endings in rat brain. Br. J. Pharmacol. 134, 46 57.
41. Sato K. Matsuki N. (2002) A 72 kDa heat shock protein is protective against the selective vulnerability of CA1 neurons and is essential for the tolerance exhibited by CA3 neurons in the hippocampus. Neuroscience 109, 745 756.
42. Sato K., Saito H. Matsuki N. (1996) HSP70 is essential to the neuroprotective effect of heat-shock. Brain Res. 740, 117 123.
43. Shankaran M., Yamamoto B. K. Gudelsky G. A. (1999) Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. Eur. J. Pharmacol. 385, 103 110.
44. Sharma H. S., Olsson Y. Westman J. (1995) A serotonin synthesis inhibitor, p-chlorophenylalanine reduces the heat shock protein response following trauma to the spinal cord: an immunohistochemical and ultrastructural study in the rat. Neurosci. Res. 21, 241 249.
45. Shen H. Y., He J. C., Wang Y., Huang Q. Y. Chen J. F. (2005) Geldanamycin induces heat shock protein 70 and protects against MPTP-induced dopaminergic neurotoxicity in mice. J. Biol. Chem. 280, 39 962 39 969.
46. Snape M. F., Baldwin H. A., Cross A. J. Green A. R. (1993) The effects of chlormethiazole and nimodipine on cortical infarct area after focal cerebral ischaemia in the rat. Neuroscience 53, 837 844.
47. Sprague J. E. Nichols D. E. (1995) Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum. Psychopharmacology (Berl) 118, 357 359.
48. Stone D. M., Merchant K. M., Hanson G. R. Gibb J. W. (1987) Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat. Neuropharmacology 26, 1677 1683.
49. Truettner J., Busto R., Zhao W., Ginsberg M. D. Perez-Pinzon M. A. (2002) Effect of ischemic preconditioning on the expression of putative neuroprotective genes in the rat brain. Brain Res. Mol. Brain Res. 103, 106 115.
50. Wang X., Baumann M. H., Xu H. Rothman R. B. (2004) 3,4- Methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse 53, 240 248.
51. Wang X., Baumann M. H., Xu H., Morales M. Rothman R. B. (2005a) (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J. Pharmacol. Exp. Ther. 314, 1002 1012.
52. Wang J. L., Ke D. S. Lin M. T. (2005b) Heat shock pretreatment may protect against heatstroke-induced circulatory shock and cerebral ischemia by reducing oxidative stress and energy depletion. Shock 23, 161 167.
53. Xie T., Tong L., McLane M. W., Hatzidimitriou G., Yuan J., McCann U. Ricaurte G. (2006) Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines. Neuropsychopharmacology Jan 25; [Epub ahead of print].
54. Yanase T., Hara S., Mukai T., Kuriiwa F., Iwata N., Kano S. Endo T. (1998) Characterization of temperature rise of the brain and the rectum following intracerebroventricular administration of alpha-amino-3-hydroxy-5- methyl-4-isoxazolepropionate and kainate in rats. Brain Res. 798, 304 310.
55. Yang Y. L., Lu K. T., Tsay H. J., Lin C. H. Lin M. T. (1998) Heat shock protein expression protects against death following exposure to heatstroke in rats. Neurosci. Lett. 252, 9 12.
56. Yenari M. A., Fink S. L., Sun G. H., Chang L. K., Patel M. K., Kunis D. M., Onley D., Ho D. Y., Sapolsky R. M. Steinberg G. K. (1998) Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann. Neurol. 44, 584 591.
57. Yenari M. A., Giffard R. G., Sapolsky R. M. Steinberg G. K. (1999) The neuroprotective potential of heat shock protein 70 (HSP70). Mol. Med. Today 5, 525 531.
58. Yuan J., Cord B. J., McCann U. D., Callahan B. T. Ricaurte G. A. (2002) Effect of depleting vesicular and cytoplasmic dopamine on methylenedioxymethamphetamine neurotoxicity. J. Neurochem. 80, 960 969.